Chronic obstructive pulmonary disease (COPD) and asthma are common complex diseases characterized by airflow obstruction and inflammatory processes in the small airways. lnterleukin 8 (IL-8) is a potent proinflammatory cytokine which interacts with the IL-8 receptor a (IL8RA, CXCR1) and b (IL8RB, CXCR2), leading to activation and migration of leukocytes. In order to evaluate the role of the IL8RA gene in the pathogenesis of COPD and asthma, we screened the coding region of IL8RA for mutations by means of single-strand conformation polymorphism analysis in 50 COPD patients and identified three exchanges (M31R, S276T and R335C). These three polymorphisms were subsequently genotyped in 182 adult patients with COPD, 68 adult patients and 130 children with asthma as well as 454 healthy controls. The frequencies of the IL8RA 31R and 335C alleles were significantly increased in patients with COPD and in children with asthma compared to healthy controls (P ¼ 0.0073 and 0.023, respectively). Thus, these polymorphisms may play a role in the pathogenesis of COPD and asthma.
Introduction
Chronic obstructive pulmonary disease (COPD) and asthma are common chronic diseases with a prevalence of B5-15% in Western Europe. 1, 2 COPD is characterized by progressive irreversible airflow limitation caused by chronic inflammation of the small airways and mainly affects adults, especially smokers. 1 Bronchial asthma, on the other hand, is the most common chronic disease in childhood and is characterized by sensitization to inhalant allergens with airway hyper-responsiveness and episodes of acute reversible airflow obstruction in the majority of cases.
2 Despite these differences in disease characteristics, there are some interesting similarities between COPD and asthma. A major feature of both disorders is airflow obstruction, determined by changes in spirometric parameters such as forced expiratory volume at 1 s (FEV 1 ) and the ratio of FEV 1 to forced vital capacity (FVC). 3 Both COPD and asthma are multifactorial diseases, with environmental as well as genetic factors influencing disease susceptibility. 4 Genome-wide screens as well as candidate gene studies have revealed multiple chromosomal regions and genes as potential susceptibility loci for both diseases, 5, 6 and there is increasing evidence that at least part of the genetic background might be common among COPD and asthma. 7 A major factor in the development and exacerbations of both COPD and asthma is an inflammatory response in the airways. Among proinflammatory cytokines, interleukin-8 (IL-8) predominantly mediates the attraction and activation of neutrophils. High concentrations of IL-8 have been observed in the bronchoalveolar fluid (BAL) and sputum of asthma 8 and COPD 9,10 patients. The IL-8 concentration was negatively correlated with the FEV 1 /FVC ratio in COPD. 11 This cytokine has also been implicated in the pathogenesis of respiratory syncytial virus (RSV) bronchiolitis 12 and cystic fibrosis, 13 and thus it appears to play an important role in the inflammatory process in several pulmonary diseases. IL-8 mediates chemoattraction via two different receptors: IL-8 receptor a (IL8RA, CXCR1) and b (IL8RB, CXCR2). IL8RA is a member of the superfamily of G-proteincoupled receptors, and is composed of seven transmembrane domains, three intracellular and three extracellular loops. 14 The IL8RA gene is localized on chromosome 2q35, close to the region of highest linkage to spirometric phenotypes for early-onset COPD in a genome-wide screen. 15 The same region also showed evidence for linkage to total serum IgE levels in patients with asthma. 16 We, therefore, considered the IL8RA gene to be a candidate predisposing for both COPD and asthma.
In order to identify genetic polymorphisms involved in predisposition for clinical manifestation of COPD and/or asthma, we first screened the coding region of the IL8RA gene by single-strand conformation polymorphism (SSCP) analysis and subsequently genotyped three exchanges in 182 adult patients with COPD, 68 adult patients and 130 children with asthma as well as 454 healthy controls. The frequencies of the IL8RA 31R and 335C alleles were significantly increased in patients with COPD as well as in children with asthma compared to healthy controls, indicating a potential role of IL8RA coding variation in COPD and asthma.
Results
Screening of the IL8RA coding region using SSCP analysis in 50 patients with COPD identified three 'missense mutations': T92G results in the substitution of a methionine by an arginine residue at position 31 (M31R), G827C causes the substitution from serine to threonine at position 276 (S276T) and C1003T leads to a substitution of arginine to cysteine at position 335 (R335C; Table 1 ). The 92G and 827C alleles harbor restriction sites for BfmI and Alw26I, respectively, which are not present in the corresponding alleles so that these variations can be genotyped by restriction enzyme digestion of the respective polymerase chain reaction (PCR) products. The R335C polymorphism was genotyped by SSCP analysis.
Evaluation of these three polymorphisms in 182 adult patients with COPD, 68 adult patients and 130 children with asthma as well as 454 healthy blood donors showed significant associations of the M31R and R335C variations with both COPD and asthma ( Table 2 ). The 31R allele was significantly more frequent in patients with COPD (19/364 ¼ 5.2%) than in healthy controls (21/ 908 ¼ 2.3%; P ¼ 0.0073). This association remained significant after Bonferroni correction. Exclusively without Bonferroni correction, significance was demonstrable for children suffering from asthma (13/260 ¼ 5%; P ¼ 0.023). A similar tendency was observed in a small sample size of adults with asthma (12/136 ¼ 4.4%; P ¼ 0.1504). Analysis of R335C revealed almost identical results, since both SNPs are in tight linkage (data not shown). As we examined more DNA samples from patients with COPD than from children and adults with asthma, the significance in patients with asthma may have been achieved by typing more DNA samples. Yet, to achieve a significance level of 0.05 with the same statistical power as for the COPD patients, a sample size exceeding 300 patients would have been required.
For the S276T variation, there was no significant difference between the allele or genotype frequencies in patients and healthy controls ( Table 2 ). The frequencies of all three SNPs were in Hardy-Weinberg equilibrium for the case and control groups.
Discussion
Several studies have pointed to the role of IL-8 as a potent chemoattractant in the inflammatory process in Table 1 IL8RA polymorphisms investigated
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C1003T-R335C C-allele: GGCACGTCAT C GTGTTACCTC T-allele: GGCACGTCAT T GTGTTACCTC Association of IL-8 receptor a polymorphisms with COPD and asthma S Stemmler et al the lungs for both COPD 9,17 and bronchial asthma. 8, 18 IL-8 mediates chemoattraction via two different receptors: IL8RA (CXCR1) and IL8RB (CXCR2). Here, we present for the first time significant association data for two coding variations in the IL8RA gene with COPD and, as a trend, also with asthma (especially in children).
We screened the entire coding region of the IL8RA gene in 50 patients with COPD and detected three missense exchanges. Two of these (S276T and R335C) have already been described by mutation screening of the CXCR1, CXCR2 and CXCR3 genes in Japanese probands. 19 The M31R variation was newly identified in our German cohorts and found to be in strong linkage disequilibrium with R335C.
The IL8RA receptor is a member of the superfamily of G-protein-coupled receptors; it consists of 350 amino acids constituting seven transmembrane domains, three intracellular and three extracellular loops. The M31R polymorphism is located in the N-terminus of the protein, the S276T polymorphism in the third extra cellular loop and the R335C polymorphism in the Cterminus of the IL-8R alpha protein. Studies on receptor/ ligand interaction suggest that the N-terminal site is important for ligand binding and sensitivity. 20, 21 Thus, one might speculate that M31R could have an effect on receptor/ligand interaction, especially since the exchange from M-R induces altered structure and charge in this position. The same applies for the exchange R-C at position 335. C residues harbor potential to form disulfide bonds (dimerization). 22 Thus, both M31R and R335C variations potentially have an impact on receptor functions by changing the secondary or tertiary structure of the receptor, respectively, while the S276T variation theoretically does not lead to major differences at this position. Interestingly, this latter polymorphism was not found to be associated with COPD or asthma in this study. Functional studies should evaluate these hypotheses.
Variation in the IL-8 gene has already been studied. A significant association has been reported between a polymorphism in the IL-8 promoter region (À251A/T) and increased risk for bronchiolitis. 12 In this study, the A allele tended to be associated with increased IL-8 production by lipopolysaccharide-stimulated whole blood. Children carrying the A allele significantly more often developed massive bronchiolitis after infection with RSV than children with other genotypes. 12 Epidemiological studies have demonstrated that severe RSV infection is a risk factor for the development of asthma in children. 23, 24 Yet, replication studies revealed conflicting results. The same promoter polymorphism also showed asthma association in a different cohort, 25 yet the opposite allele was associated with increased risk for disease. Haplotype analyses across the region further revealed that the À251A/T variation might not be functional itself, but rather residing on the risk haplotype. 26 ,27 Furthermore, we also found no association of this IL-8 promoter polymorphism, neither with asthma nor COPD, previously. 28 Examining possible interaction effects of variations in both the IL-8 and IL8RA genes are mandatory in order to reveal whether gene/gene interactions play a role as has, for example, been demonstrated for the IL4, IL13 and IL4RA genes. [29] [30] [31] Interestingly, we found association of an IL8RA allele with both COPD and asthma in children (although the latter lost significance after Bonferroni correction). This finding supports ideas that although asthma and COPD are distinct diseases, at least part of the genetic susceptibility to both diseases might be common. 7 In fact, the IL8RA region on chromosome 2q showed significant linkage to the FEV 1 /FVC ratio in a genomewide screen of COPD families. 32, 33 The same region showed evidence for linkage to total serum IgE levels in patients with asthma. 16 Associations of total serum IgE levels with asthma and bronchial hyper-responsivness have been demonstrated. 34, 35 Thus, our findings generate initial evidence that variation in the IL8RA gene might be responsible for 'linkage' observed for both COPD and IgE levels to this region. Yet, other positional candidates cannot be excluded, and the association could be due to the existence of a different susceptibility locus that is in linkage disequilibrium. The fact that we did not see an association of IL8RA with asthma in adults might be due to the small sample size in this group (n ¼ 68). Yet, we saw a similar trend even for this small group of adult asthma patients and the significance may have been achieved by typing more samples. In order to achieve the same statistical power as for COPD patients, a sample size of about 300 patients would have been required.
Associations between polymorphisms in other chemokine receptor genes and asthma have been reported. A 32 bp deletion in the CCR5 gene was associated with reduced risk for asthma. 36 Two studies confirmed this finding, 37, 38 while others failed to replicate the results. 39, 40 Furthermore, a silent mutation in the CCR3 gene was associated with asthma in a British, but not a Japanese population. 41 Association of a chemokine receptor allele with COPD has not yet been reported. Chemokine receptors have gained substantial attention recently since antagonists of these receptors are being discussed as a novel treatment option for both asthma 42 and COPD. 43 Variation in chemokine receptor genes and receptor/ligand binding might be crucial for future treatment options. Functional studies of the polymorphisms and their potential effect(s) on binding of IL-8 as well as association studies in other cohorts are needed to further elucidate their role in pulmonary diseases.
Materials and methods

Subjects
In all, 182 unrelated adult patients with COPD and 68 unrelated adult patients with asthma were recruited while hospitalized and 130 unrelated children with asthma were recruited while attending the ambulatory clinic at the University Hospital, Berufsgenossenschaftliche Kliniken Bergmannsheil (Bochum, Germany). All patients included in the study were of German origin. Mean age was 68 years (range 33-81 years ) for COPD patients, 9.5 years (range 2-15 years ) for children with asthma and 38 years (range 18-68 years) for adult asthmatics (Table 3 ). The diagnoses were made based on the standards of the American Thoracic Society 44 and the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. 3 Pulmonary function testing was performed as described before. 45 In brief, FEV 1 and FEV 1 /FVC were assessed applying a JAEGER Flowscreen device (E.JAEGER Hoechberg,
. The best out of three trials was selected and data were compared to reference values. Mean FEV 1 was 47719% of the predicted value for COPD patients, 73725% for adult asthmatics and 97718% for asthma children (Table 3) . Informed consent was obtained for all subjects. Control samples from over 450 healthy German blood donors were collected at the Departments of Transfusion Medicine of the University Hospitals in Essen and Hamburg (Germany). A subset of this control group was previously included in a genome-wide association screen with 4666 microsatellites and hidden stratification of the population has been excluded. 46 DNA was extracted from EDTA-anticoagulated peripheral blood by using a standard salting-out method. 47 
SSCP analyses
Polymorphism screening of the entire coding region of the IL8RA gene was performed in 50 COPD patients, constituting a subset of the total COPD group recruited for this study, using PCR with consecutive SSCP analysis. In order to cover 2398 bp of nucleotide sequence, seven overlapping PCR fragments were designed. PCR reactions were performed in a total volume of 10 ml, containing 50 ng DNA, 200 mmol of each dNTP, 1 mmol MgCl 2 , 10 pmol of each primer, 0.4 U Taq polymerase (Genecraft, Mü nster, Germany) and 0.08 ml [
32 P]a-CTP (10 mCi/ml). Thermal cycling was performed in a Robocycler (Stratagene, Amsterdam, Holland). After two initial cycles at 6 and 31C above the annealing temperature, 27 cycles of 951C (45 s), annealing temperature (45 s) and 721C (30 s) were run. For each of the seven PCR fragments, primer sequences and annealing temperatures are shown in Table 4 . For SSCP analysis, 3 ml of PCR product was mixed with 7 ml of SSCP loading buffer (95% formamide, 20 mM EDTA, 0.05% xylene cyanol and 0.05% bromophenol blue), denatured at 951C for 5 min and then immediately cooled on ice. A measure of 3 ml of this mix was run on 6% polyacrylamide gels (38% acrylamide, 2% bisacrylamide) containing 1 Â TBE buffer (890 mM Tris-borate, 20 mM EDTA, pH 8.3), 5% glycerine and 6% urea or 10% glycerine in a SQ3 apparatus (Hoefer, Freiburg, Germany) at 45 W for 3 1 2 h. During SSCP analysis, the temperature was constantly 41C. SSCP gels were dried and autoradiography films applied for 1-4 days.
DNA sequencing DNA samples with peculiar separation behavior on SSCP gels were directly sequenced using the BigDye cycle sequencing Kit (Applied Biosystems, Darmstadt, Germany) as described in the manufacturer's instructions on an automated sequencer (ABI PRISM 373, DNA Sequencer).
Genotyping IL8RA M31R and S276T variations were genotyped by restriction enzyme digestion. Patient and control samples were amplified using the same primers and conditions as described above, except for the inclusion of radioactivity. A measure of 10 ml of the PCR products were digested with 2 U of BfmI (IL8RA M31R) and 1.5 U of Alw26I (IL8RA S276T) at 371C for 3 h. The fragments were then separated on 2.5% (IL8RA M31R) and 2% (IL8RA S276T) agarose gels in 1 Â TBE buffer (30 min, 200 V) and visualized using ethidium bromide staining. For IL8RA M31R, a second restriction side for BfmI was included in Association of IL-8 receptor a polymorphisms with COPD and asthma S Stemmler et al the amplicon and the additional band was used as an internal quality control. IL8RA R335C was genotyped by SSCP as described above.
Statistics
Allele and genotype frequencies were ascertained by direct counting and subsequently compared using the w 2 method. Bonferroni correction for multiple testing was applied. Deviations from Hardy-Weinberg equilibrium were evaluated using the FINETTI program. Po0.05 was considered to be significant. Power calculations were performed using the Power and sample size program (www.mc.vanderbilt.edu/prevmed/ps).
